What is the requirement for selling low-dose codeine preparations in terms of consumer limits?

The requirement for selling low-dose codeine preparations focuses on ensuring proper monitoring and control over the distribution of these medications. Documenting every sale provides a clear trail of transactions that can be reviewed if needed, which is crucial for preventing misuse or overuse of codeine products. This practice is in line with regulations designed to protect public health and ensure that these medications are being used appropriately. By requiring documentation, pharmacies can track sales patterns and identify any potential misuse, allowing for responsible dispensing practices.

Other options, while they might seem reasonable, do not align with the regulatory framework in place for low-dose codeine. While limiting the quantity sold per transaction or setting a maximum per week might be effective in other contexts, the emphasis on documentation ensures that there is a comprehensive record available for regulatory oversight. Thus, documenting each sale is an essential part of maintaining accountability and safety in the handling of low-dose codeine preparations.